Allogeneic Natural Killer (NK) Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic Natural Killer (NK) Cells, covering 2010-08-12 to 2017-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies [Phase 2]